All News

ASCO and AACR want to see stricter regulation of the products, touching various aspects such as flavors, child-proofing, refills etc.

For the first time in the United States, doctors used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one — and placed it just outside the heart.

The Affordable Care Act was implemented to change healthcare in the United States. In order to support that change, the government established the Center for Medicare and Medicaid Innovation (CMMI)-a sector of the government agency that aims to incentivize innovation among providers and payers.

Marketed by Genentech, Avastin received priority review following encouraging safety and efficacy results.

The final decision on the proposal will be made only after a 30-day comment period.

Both, the scientific community and a charitable organization, Prostate Cancer UK, have criticized the drug approval body for not offering abiraterone to sufferers until after chemotherapy.

HHS said that many Medicare Advantage plans wrongly inflated patient risk scores, costing the government billions. Although no insurers were specifically named, HHS researchers said it was evident that the practice of overbilling was occurring industry wide.

The FDA, in a press release, has warned consumers to be aware of such products being sold online.

To keep their healthcare costs in check, employers are shifting the cost equation by increasing employee premiums.

The study, published in Lancet, reaffirms that being obese and overweight can be a major health burden and can lead to various other diseases.

However, insurers want the government to intervene and restrict the practice.

A recent Facebook study has initiated a debate on privacy and ethicis concerns, with the Federal Trade Commission saying they'll soon be involved as well.

Kyprolis failed to improve survival in the phase 3 FOCUS trial in patients who had relapse following at least 3 prior regimens.

Scientists at Hopkins are working on developing a test that can rapidly sequence cellular DNA in a blood sample for early diagnosis of cancer, which could have a tremendous potential in asymptomatic subtypes of the disease.

With the speed at which technology advances, it can be surprising that the majority of US medical records are not yet available electronically - but the nation is gradually making the transition to great electronic health record (EHR) use.

CMS provided COA a draft of an episode-based payment model being developed at their Innovation Center. COA has been in collaboration with CMS on developing this model.

The gene, normally expressed only in a developing embryo, was found expressed in several different childhood cancers.

With the aim to authenticate and regulate medical information, Cancer Research UK plans to provide the most up-to-date and accurate healthcare information.

WellPoint Inc is planning on changing its name to Anthem to eliminate brand confusion and better connect with consumers.

Cologuard had received recommendation for premarket approval from a FDA advisory panel back in March.

The concept of a single-payer health system remains somewhat controversial among some legislators, yet Vermont continues to embrace the transition despite the challenges.

Next year, U.S. healthcare providers will be subject to Medicare penalties if they do not meet up to 26 measures for value-based purchasing.

The study, published in the Journal of Clinical Oncology, examined national statistics for the period between 2007 to 2010 for people aged 18-64 of age.

Specialty drugs expected to account for 40% of total prescription spending by 2016, according to Catamaran Corporation.

Using the genome editing tool known as CRISPR, researchers were able to selectively silence two genes in HPV that are responsible for the growth and survival of cervical carcinoma cells.

The approval follows results from the RETRIEVE trial, conducted in patients who had previously responded to Velcade but had relapsed.

Although the overall rate of NSCLC is lower, certain subtypes of the disease fared better than others, the study published in the journal Cancer found.

New research found that the risk of developing breast cancer increased in women who had mutations of a gene related to BRCA2, the PALB2 gene.

Bottom line: Sovaldi will not save the system money. It will cost money-a lot of money-to reduce premature mortality due to chronic hepatitis C infection.